A Systematic Review of Cross-Lingual Sentiment Analysis: Tasks, Strategies, and Prospects
ACM Computing Surveys · 31.07.2024 · 56 (7) · 1-37
DOI: 10.1145/3645106 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift ACM Computing Surveys, online erschienen am 09.04.2024. Verfasst von Chuanjun Zhao und 6 weiteren Autor:innen. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 174 Literaturangaben.
Abstract (Originalsprache)
Traditional methods for sentiment analysis, when applied in a monolingual context, often yield less than optimal results in multilingual settings. This underscores the need for a more thorough exploration of cross-lingual sentiment analysis (CLSA) methodologies to improve analytical effectiveness. CLSA, confronted with obstacles such as linguistic disparities and a lack of resources, seeks to evaluate sentiments across a range of languages. First, the research background, challenges, existing solution ideas, and evaluation tasks of CLSA are summarized. Subsequently, new perspectives including different granularity levels, machine translation support, and sentiment transfer strategies perspectives are highlighted. Finally, potential avenues for future research are discussed.
Zitieren
APA
Zhao, C., Wu, M., Yang, X., Zhang, W., Zhang, S., Wang, S., & Li, D. (2024). A Systematic Review of Cross-Lingual Sentiment Analysis: Tasks, Strategies, and Prospects. ACM Computing Surveys, 56(7), 1-37. https://doi.org/10.1145/3645106
Vancouver
Zhao C, Wu M, Yang X, Zhang W, Zhang S, Wang S, et al. A Systematic Review of Cross-Lingual Sentiment Analysis: Tasks, Strategies, and Prospects. ACM Computing Surveys. 2024;56(7):1-37. doi:10.1145/3645106
BibTeX
@article{Zhao2024,
author = {Zhao, Chuanjun and Wu, Meiling and Yang, Xinyi and Zhang, Wenyue and Zhang, Shaoxia and Wang, Suge and Li, Deyu},
title = {A Systematic Review of Cross-Lingual Sentiment Analysis: Tasks, Strategies, and Prospects},
journal = {ACM Computing Surveys},
year = {2024},
volume = {56},
number = {7},
pages = {1--37},
doi = {10.1145/3645106}
}
EUVIMED